chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a RN concerning a male 16 years old and readying for college at the time of this report who on an unknown date was vaccinated with a dose of  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). It was reported that the pt reacts of live MMR II combo vaccine and had a reaction of measles so they consider this from the MMR II and is a reaction against the combo. It was also reported that the pt has no immunity to mumps via testing. It was noted that this was reported a long time ago when the child was young. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Condition aggravated, Thrombocytopenic purpura
Clinical narrative: Information has been received from a physician concerning a female with a history of idiopathic thrombocytopenia purpura who at 16 months of age, in approximately 1993, was vaccinated with MMR (second generation). The patient's idiopathic thrombocytopenic purpura was treated with steroids and IVIG. The patient's idiopathic thrombocytopenic purpura cleared at approximately 3 years of age. Upon medical review, idiopathic thrombocytopenic purpura was considered an other important medical event (OMIC). Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Erythema, Swelling
Clinical narrative: Information has been received from a health professional concerning a 4 year old male with mild pulmonary valve stenosis and a cough (for 3 weeks per pt's mother) who on 05Jun03, at 11:00AM was vaccinated SC in the left arm with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). On 06Jun2003 the pt's left upper arm became red with sterile swelling. Subsequently, the pt recovered from the left upper arm redness and sterile swelling. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, MMR
Symptoms: Swelling
Clinical narrative: Information has been received from a consumer and follow up information from someone at a physician's office concerning a 5 year old pt with sinusitis at the time of vaccination no other medical history and no allergies. It was reported that there were no adverse events following prior vaccinations. On 22May2003 at 3:15PM the pt was vaccinated SC in the right arm with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant therapy included vaccination IM in the left arm on 22May03 with a dose of diphtheria toxoid (+) hepatitis B vaccine recombinant (yeast) (+)  pertussis vaccine (+) Poliovirus vaccine inactivated (+) tetanus toxoid (PEDIARIX). It was initially reported by the consumer that three to four days following vaccination, the pt developed a swelling on the back of her hands, just below the wrist and the swelling was reported to be the size of a silver dollar. The swelling went up and down, but had not gone away. The pt saw the doctor about this, but it was reported that the doctor did not seem to know what it was. Follow up information reported that on 10Jun03 at 4:45PM the pt developed swelling of the wrist with required a doctor's visit. Laboratory testing was done-see lab data. The outcome was reported as unknown. Follow up information also noted that vaccination with a first dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (manufacturer UNK) was received on 06Aug1998. It was not clearly reported if it was the pt or a sibling who received the vaccine and no adverse events were reported in relation to that vaccine. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Medication error
Clinical narrative: Information has been received form an emergency medical technician concerning a 4 year old female pt with no medical history reported, although it was noted that allergy not available at this time. On 01Jul03 the pt was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). There were no concomitant medications. The vaccine was reconstituted with sterile saline instead of the required diluent. It was reported that the pt returned to the clinic on 02Jul03 with an injection site reaction that is red, edematous and painful. The emergency medical technician reported that the pt was being seen by the physician and treatment was not yet known. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a mother concerning her 15 month old female daughter who on 23Jun2003 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) SC administration. Concomitant medications were not provided. On 28Jun2003, the pt developed fever of 103 for 3 days (June 28th through the 29th). It was unknown if the pt recovered from fever. The pt was seen by her physician but the cause of her fever was unknown. No product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Nonspecific reaction
Clinical narrative: Information has been received from a RN concerning a Hispanic male, who as a child was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). The pt stated that his mother told him that he had an adverse reaction to the vaccine when he was a child. Additional information has been requested. It was noted that the pt had an experience following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) when he was 38 years old.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a RN with environmental allergies and no significant health history who in 1996 was vaccinated with a booster dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). She had previously been vaccinated as a child with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). There were no concomitant medications. Subsequently laboratory evaluation revealed that a titer, which was done on an unspecified date, was negative for mumps. No adverse symptoms were reported. Unspecified medical attention was sought. The RN also reported that her son had experienced pervasive developmental disorder ADHD, autism, severe dairy allergy, cellulitis at injection site and a negative titer for mumps. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Pyrexia, Rash, Rash macular
Clinical narrative: Information has been received from a mother concerning her 12 month old daughter who on 26Jun03 at 4:50PM (also reported as 27Jun03) was vaccinated SC into the left thigh with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). There was no concomitant medication. Ten to twelve days later the pt broke out in big red blotchy patches that appeared on her legs, belly and face and this lead to little scabby dots on the child's body. The pt's mother took her to the physician. The physician thought that the pt might have had a slight case of the measles. However it was reported that the pinpoint went away in 2 days and then the physician thought the cause may have been due to the pt's fever. The physician also thought according to the pt's mother, that the pt might have hives but after the hives did not go away over a period of time the physician thought otherwise. It was reported that hives generally go away after a period of time and new ones appear. The pt is still experiencing the big red blotchy patches and scabby dots on child's body. No further information was provided. Follow up information has been received from a nurse practitioner which indicated that the pt presented to the office with a rash, hives and fever on 08Jul03. It was noted that all symptoms had resolved per the reporter. There are no ongoing problems according to the chart. It was reported that this does not appear to be an adverse event. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a female physician assistant with no known allergies, who was vaccinated SC with four doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the last ten years. Concomitant therapy included hormonal contraceptives (unspecified). Subsequently the pt never seroconverted to measles but has seroconverted to mumps and rubella. No lot numbers were available. No other information was provided. Unspecified medical attention was sought. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Erythema, Skin nodule, Vomiting
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old white female patient, with no medical history or allergies, who on 10-Jul-2003 at 4:30 pm was vaccinated SC into the left thigh with a first dose of MMR vaccine live (second generation) (lot #644581/1082M). Concomitant therapy on 10-Jul-2003 included a first dose of varicella virus vaccine live (lot #644569/1158M) SC into the right thigh and a third dose of Streptococcus pneumoniae vaccine (PREVNAR) (lot #492-815) IM into the right thigh. It was reported that the patient was not ill at the time of vaccination. On 10-Jul-2003 the mother called and stated that the patient's left thigh was reddened and "baseball size." The patient's mother was advised to use warm compresses, anti-pyretic and anti-inflammatory medications, and to seek medical attention if symptoms worsened and/or any respiratory or generalized symptoms occurred. It was reported that the patient vomited and was seen in the emergency room. The patient was monitored, was given ibuprofen (MOTRIN) and electrolytes (unspecified) (PEDIALYTE). It was reported that "today" the doctor examined the patient, monitored and gave fluids. During a public health nurse (PHN) home visit, it was reported that there was no redness or swelling noted and there was good strength and movement. It was reported that the patient recovered on 11-Jul-2003. Additional information is not expected.
Age: 1.25
Sex: F
Vaccine: MMR, PNC
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician's assistant concerning a 15 month old female patient, who is "slow to gain weight" and has a history of "borderline" failure to thrive and no allergies, who on 08-Jul-2003 at 15:00 was vaccinated with a first dose of MMR vaccine live (second generation) (lot #639914/0023M) into the left thigh. Concomitant therapy on 08-Jul-2003 at 15:00 included a fourth dose of Streptococcus pneumoniae vaccine (PREVNAR) (lot #484-150) into the left thigh. It was reported that the patient was not ill at the time of vaccination. It was noted that the patient had no adverse symptoms noted with prior vaccinations or previous 3 doses of PREVNAR. On 16-Jul-2003 the patient developed generalized urticaria. According to the reporter there was no lip swelling, angioedema, cough or wheezing. The reporter was "not convinced" that the urticaria was related to the MMR vaccine live (second generation) because it did not occur until 8 days later. The patient was treated with diphenhydramine hydrochloride (Benadryl) and recovered on 20-Jul-2003. It was reported that the patient had not eaten anything on the day of the urticaria that she had not eaten in the past. Additional information is not expected.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Nausea, Rash pruritic, Skin burning sensation
Clinical narrative: Information has been received from a nurse practitioner concerning a 30 year old female who on 03-Jul-2003 was vaccinated with a dose of MMR vaccine live (second generation) (lot #642968/0530M). Concomitant therapy included cetirizine hydrochloride (Zyrtec) being taken PRN for an unknown indication. On 16-Jul-2003 the patient developed a widely disseminated, itchy, burning, red, but not raised rash and nausea. The patient sought unspecified medical attention. Additional information has been requested.
Age: 32.0
Sex: F
Vaccine: HEPA, IPV, MMR, YF
Symptoms: Face oedema, Parotid gland enlargement, Parotitis, Tenderness, Thyroiditis
Clinical narrative: Information has been received from a physician concerning a 32 year old Hispanic female patient who on 29-May-2003 was vaccinated SC into the left deltoid with MMR vaccine live (second generation) (number of previous doses unknown) (lot #642440/0233M). Concomitant therapy on 29-May-2003 included a first dose of yellow fever virus vaccine live (Yellow fever vaccine) (lot #UB359AA) SC into the right deltoid, poliovirus vaccine inactivated (number of previous doses unknown) (lot #T0697) SC into the right deltoid and a first dose of hepatitis A vaccine (Havrix) (lot #VHA745A6) SC into the left deltoid. It was noted that the patient was not ill at the time of vaccination. On 15-Jun-2003 the patient developed facial swelling and tenderness. She saw another physician on 18-Jun-2003 and was felt to have parotitis and thyroiditis. The reporter indicated that upon examination on 26-June-2003 the patient had moderately enlarged parotids and a 2-3 X enlarged and tender thyroid. Another physician prescribed amoxicillin/clavulante for sinusitis. The patient's sinusitis showed no improvement upon a second exam on 03-Jul-2003 but the parotitis and thyroiditis had improved but not resolved. Laboratory findings from 23-Jun-2003 included: thyroid stimulating hormone 9.84, thyroxine 9.0, free T4 1.1 and total T3 123. On 26-Jun-2003 results included: plasma sodium 139, plasma potassium 3.8, plasma chloride 102, plasma carbon dioxide 23.7, calcium 9.3, plasma urea nitrogen 13, plasma creatinine 1.0, plasma glucose 75, total protein 8.1, albumin 4.4, globulin, 3.7m total bilirubin 0.3, alkaline phosphatase 54, transaminase SGPT 23, transaminase SGOT 20 and thyroid autoantibodies 33.8. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Irritability, Musculoskeletal stiffness
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and was assigned a manufacturer report number. A 4 year old female with no  prior medical history or concurrent conditions  was vaccinated on 17Apr03 with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) SC in the right deltoid. Concomitant vaccination on 17Apr03 included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) SC in the left deltoid. There were no other concomitant medications. It was unknown if the pt had an illness at the time of vaccination. On 18Apr03, twenty four hours post vaccination, the pt developed an injection site reaction characterized by pain, swelling and inflammation at the injection site. The pt's left arm was stiff. The pt also developed irritability and a low grade fever. On 20Apr03 the pt recovered.   The nurse considered the events to be related to vaccination with diphtheria toxoid/pertussis vaccine/tetanus (INFANRIX). It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information was received from a RN who stated that the reaction was at the site of the diphtheria toxoid/ pertussis  vaccine/ tetanus (INFANRIX) in the deltoid. There was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) was that it was given at the same time. The reporter stated that to her knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment. No diagnostic work up or laboratory tests were performed.  The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid/ pertussis vaccine/ teta (INFANRIX). Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and was assigned a manufacturer report number. A 4 year old female with no  prior medical history or concurrent conditions  was vaccinated on 17Apr03 with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) SC in the right deltoid. Concomitant vaccination on 17Apr03 included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) SC in the left deltoid. There were no other concomitant medications. It was unknown if the pt had an illness at the time of vaccination. On 18Apr03, twenty four hours post vaccination, the pt developed an injection site reaction characterized by pain, swelling and inflammation at the injection site. The pt's left arm was stiff. The pt also developed irritability and a low grade fever. On 20Apr03 the pt recovered.   The nurse considered the events to be related to vaccination with diphtheria toxoid/pertussis vaccine/tetanus (INFANRIX). It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information was received from a RN who stated that the reaction was at the site of the diphtheria toxoid/ pertussis  vaccine/ tetanus (INFANRIX) in the deltoid. There was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) was that it was given at the same time. The reporter stated that to her knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment. No diagnostic work up or laboratory tests were performed.  The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid/ pertussis vaccine/ teta (INFANRIX). Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site reaction, Injection site swelling, Irritability
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and was assigned a manufacturer report number concerning a 5 year old male with no concurrent conditions or past medical history who on 17Mar03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant vaccination, that same day,  included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. There were no other concomitant therapy. On 18Mar03, twenty four hours post immunization, the pt developed an injection site reaction characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Mar03.   The reporting nurse considered the events to be related to Infanrix administration. It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information from the RN indicated that the reported reaction was at the site of the diphtheria toxoid/ pertussis  vaccine/ teta (INFANRIX), in the deltoid. She reported that there was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) injection site. She noted that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) that there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment.  The same reporter indicated 4 other pt's who had similar reactions  following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid/ pertussis vaccine/ teta (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Musculoskeletal stiffness, Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and was assigned a manufacturer report number concerning a 5 year old male with no concurrent conditions or past medical history who on 17Mar03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant vaccination, that same day,  included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. There were no other concomitant therapy. On 18Mar03, twenty four hours post immunization, the pt developed an injection site reaction characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Mar03.   The reporting nurse considered the events to be related to Infanrix administration. It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information from the RN indicated that the reported reaction was at the site of the diphtheria toxoid/ pertussis  vaccine/ teta (INFANRIX), in the deltoid. She reported that there was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) injection site. She noted that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) that there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment.  The same reporter indicated 4 other pt's who had similar reactions  following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid/ pertussis vaccine/ teta (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Agitation, Injection site inflammation, Injection site oedema, Injection site pain, Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and was assigned a manufacturer report number concerning a 5 year old male with no concurrent conditions or past medical history who on 17Mar03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Concomitant vaccination, that same day,  included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. There were no other concomitant therapy. On 18Mar03, twenty four hours post immunization, the pt developed an injection site reaction characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Mar03.   The reporting nurse considered the events to be related to Infanrix administration. It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information from the RN indicated that the reported reaction was at the site of the diphtheria toxoid/ pertussis  vaccine/ teta (INFANRIX), in the deltoid. She reported that there was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) injection site. She noted that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) that there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment.  The same reporter indicated 4 other pt's who had similar reactions  following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid/ pertussis vaccine/ teta (INFANRIX). Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Irritability, Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer report number. A 4 year old male with no relevant medical history or concurrent conditions was vaccinated on 07May03 with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) SC in the right deltoid. Concomitant vaccination on 07May03 included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) SC in the left deltoid. There were no other concomitant medications. It was reportedly unknown if the pt had any illness at the time of vaccination.  On 08May03 the pt developed  pain, swelling and inflammation at the injection site, irritability and a low grade fever. On 10May2003 the pt recovered.  The reporter felt that pain at injection site, swelling at injection site, inflammation at injection site, irritability, and a low grade fever were related to therapy with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). It was noted that the pt had no adverse experiences following previous immunizations. This was originally reported by a RN.   Follow up information was received from a RN who stated that the reaction was at the site of the diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) in the deltoid. There was no erythema, tenderness, or swelling at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) vaccine was that it was given at the same time. The reporter stated that to her knowledge, the reaction was self-limiting and that the pt did not see a physician for treatment.  The same reporter indicated 4 other pt's who had similar reactions  following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site reaction, Injection site swelling, Irritability
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer report number. A 5 year old male with no known allergies, relevant medical history, or concurrent conditions was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on 17Apr2003. Concomitant vaccination on the same day included an IM fifth dose in the left deltoid of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX), and a SC dose in the left deltoid of poliovirus vaccine inactivated (IPOL). On 18Apr03, 24 hours post immunization, the pt experienced an injection site reaction in the left deltoid at the site of the diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) injection which was characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Apr03. It was noted that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The reporter indicated that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self limiting. The pt did not see a physician for treatment. It was noted that the pt had no adverse experiences following previous immunizations. The reporter considered the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). This was originally reported by a RN.   The nurse reported similar reactions in four other pt's following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Musculoskeletal stiffness, Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer report number. A 5 year old male with no known allergies, relevant medical history, or concurrent conditions was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on 17Apr2003. Concomitant vaccination on the same day included an IM fifth dose in the left deltoid of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX), and a SC dose in the left deltoid of poliovirus vaccine inactivated (IPOL). On 18Apr03, 24 hours post immunization, the pt experienced an injection site reaction in the left deltoid at the site of the diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) injection which was characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Apr03. It was noted that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The reporter indicated that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self limiting. The pt did not see a physician for treatment. It was noted that the pt had no adverse experiences following previous immunizations. The reporter considered the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). This was originally reported by a RN.   The nurse reported similar reactions in four other pt's following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Irritability, Musculoskeletal stiffness
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer report number. A 5 year old male with no known allergies, relevant medical history, or concurrent conditions was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on 17Apr2003. Concomitant vaccination on the same day included an IM fifth dose in the left deltoid of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX), and a SC dose in the left deltoid of poliovirus vaccine inactivated (IPOL). On 18Apr03, 24 hours post immunization, the pt experienced an injection site reaction in the left deltoid at the site of the diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) injection which was characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Apr03. It was noted that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The reporter indicated that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self limiting. The pt did not see a physician for treatment. It was noted that the pt had no adverse experiences following previous immunizations. The reporter considered the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). This was originally reported by a RN.   The nurse reported similar reactions in four other pt's following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer report number. A 5 year old male with no known allergies, relevant medical history, or concurrent conditions was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on 17Apr2003. Concomitant vaccination on the same day included an IM fifth dose in the left deltoid of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX), and a SC dose in the left deltoid of poliovirus vaccine inactivated (IPOL). On 18Apr03, 24 hours post immunization, the pt experienced an injection site reaction in the left deltoid at the site of the diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) injection which was characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low grade fever. The events resolved on 20Apr03. It was noted that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The reporter indicated that the only relationship to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) there would be in this case was that it was given at the same time. To the reporter's knowledge, the reaction was self limiting. The pt did not see a physician for treatment. It was noted that the pt had no adverse experiences following previous immunizations. The reporter considered the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). This was originally reported by a RN.   The nurse reported similar reactions in four other pt's following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site reaction, Injection site swelling, Irritability
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer control number. Information was received from a nurse concerning a 5 year old female with no known medical history, no known allergies and no concurrent conditions who on 17Apr03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation. Concomitant vaccination the same day included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. On 18Apr03, 24 hours after immunization, the pt experienced an injection site reaction in the left deltoid that included pain, swelling and inflammation. Her left arm was stiff and she also experienced irritability and low grade fever. On 20Apr03 the pt recovered. The nurse reported that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The nurse considered that the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). It was reported that the pt had no adverse experiences following previous vaccinations. The child did not see a physician for treatment. The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Musculoskeletal stiffness, Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer control number. Information was received from a nurse concerning a 5 year old female with no known medical history, no known allergies and no concurrent conditions who on 17Apr03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation. Concomitant vaccination the same day included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. On 18Apr03, 24 hours after immunization, the pt experienced an injection site reaction in the left deltoid that included pain, swelling and inflammation. Her left arm was stiff and she also experienced irritability and low grade fever. On 20Apr03 the pt recovered. The nurse reported that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The nurse considered that the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). It was reported that the pt had no adverse experiences following previous vaccinations. The child did not see a physician for treatment. The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Irritability, Musculoskeletal stiffness
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer control number. Information was received from a nurse concerning a 5 year old female with no known medical history, no known allergies and no concurrent conditions who on 17Apr03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation. Concomitant vaccination the same day included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. On 18Apr03, 24 hours after immunization, the pt experienced an injection site reaction in the left deltoid that included pain, swelling and inflammation. Her left arm was stiff and she also experienced irritability and low grade fever. On 20Apr03 the pt recovered. The nurse reported that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The nurse considered that the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). It was reported that the pt had no adverse experiences following previous vaccinations. The child did not see a physician for treatment. The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Pyrexia
Clinical narrative: This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer control number. Information was received from a nurse concerning a 5 year old female with no known medical history, no known allergies and no concurrent conditions who on 17Apr03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation. Concomitant vaccination the same day included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. On 18Apr03, 24 hours after immunization, the pt experienced an injection site reaction in the left deltoid that included pain, swelling and inflammation. Her left arm was stiff and she also experienced irritability and low grade fever. On 20Apr03 the pt recovered. The nurse reported that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The nurse considered that the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). It was reported that the pt had no adverse experiences following previous vaccinations. The child did not see a physician for treatment. The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Pyrexia, Rash erythematous, Rash maculo-papular, Rash pruritic
Clinical narrative: Information has been received from a nurse practitioner concerning a 45 year old female pt with hypertension NOS and an allergy to Macrodantin who on 09Jul03 was vaccinated SC into the left arm with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (number of previous doses UNK). It was noted that the pt was well at the time of vaccination and did not have any problems with previous vaccinations. It was unknown if the pt received measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the past. Concomitant medications include an "unnamed hypertension medication". On 20Jul03 the pt developed non tender swollen lymph glands of the neck (left anterior cervical node). On 21Jul03 a pruritic macular papular, erythematous rash on the neck, arm, chest and abdomen was noted. A slight fever (99.2 degrees F) was also reported. The only treatment the pt received was acetaminophen (Tylenol) and diphenhydramine hydrochloride (Benadryl) as needed. It was noted that the pt had recovered on 24Jul03. Additional information is not expected.